These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5048396)

  • 21. [Pulmonary hypertension in sarcoidosis].
    Shatalov NN; Guseĭnov SN; Kornev BM; Anisimov LL
    Probl Tuberk; 1982 Apr; (4):40-4. PubMed ID: 7088938
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary function studies in sarcoidosis.
    Esposito V; Barbati R; Lorusso F
    Arch Monaldi; 1984; 39(1-2):91-4. PubMed ID: 6532353
    [No Abstract]   [Full Text] [Related]  

  • 23. [The decrement of diffusing capacity observed by corticosteroid therapy in sarcoidosis (author's transl)].
    Araki T; Matsuoka R; Okazaki N; Hara H; Kuratomi Y; Natori H; Arai T; Kita S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Nov; 18(11):809-14. PubMed ID: 7289244
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lung function in the early stages of sarcoidosis].
    Grebska E; Krychniak W; Decker E
    Pneumonol Pol; 1982 Sep; 50(9):437-43. PubMed ID: 7163001
    [No Abstract]   [Full Text] [Related]  

  • 25. [Usefulness of DLco for the early diagnosis of pulmonary involvement in collagen diseases].
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):480-5. PubMed ID: 8515621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary sarcoidosis--old problems and new insights.
    Benatar SR
    Postgrad Med J; 1988; 64 Suppl 4():56-63. PubMed ID: 3076935
    [No Abstract]   [Full Text] [Related]  

  • 27. Bone marrow phagocytosis in sarcoidosis.
    Taylor HG; Berenberg JL
    Arch Intern Med; 1982 Mar; 142(3):479-80. PubMed ID: 7065786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary diffusion in progressive chronic polyarthritis].
    Mohorn R; Mohorn M; Jäger L
    Beitr Rheumatol; 1973; 20():86-95. PubMed ID: 4775431
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane diffusion in diseases of the pulmonary vasculature.
    Oppenheimer BW; Berger KI; Hadjiangelis NP; Norman RG; Rapoport DM; Goldring RM
    Respir Med; 2006 Jul; 100(7):1247-53. PubMed ID: 16376536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional changes in pulmonary sarcoidosis from the viewpoint patient material at Golnik].
    Stangl B; Fortic M; Bizjak M; Mesic J
    Plucne Bolesti Tuberk; 1973; 25(1):193-202. PubMed ID: 4794419
    [No Abstract]   [Full Text] [Related]  

  • 31. Sarcoidosis and the diffusing capacity for carbon monoxide.
    Sietsma K
    Sarcoidosis; 1990 Mar; 7(1):12-4. PubMed ID: 2345815
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical application of the results of respiration biomechanics tests in patients with lung sarcoidosis].
    Evfim'eveskiĭ VP; Romanov VV; Nefedov VB
    Probl Tuberk; 1982 Apr; (4):38-40. PubMed ID: 7088937
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity.
    Ferguson MK; Gaissert HA; Grab JD; Sheng S
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1297-302. PubMed ID: 19783010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gas exchange during mild hypoxic exercise in normal subjects and patients with lung disease.
    McHardy GJ; Clark RA; Tarala RA
    Scand J Respir Dis Suppl; 1971; 77():45-8. PubMed ID: 5288478
    [No Abstract]   [Full Text] [Related]  

  • 36. Sarcoidosis: course and treatment.
    Colp C
    Med Clin North Am; 1977 Nov; 61(6):1267-78. PubMed ID: 926892
    [No Abstract]   [Full Text] [Related]  

  • 37. [Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise].
    Chi L; Liu Y; Piao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):344-7. PubMed ID: 11326890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diffusing capacity in lung impairment resulting from chronic progressive polyarthritis].
    Tallósy I; Vargha G
    Orv Hetil; 1986 Aug; 127(32):1937-9. PubMed ID: 3763206
    [No Abstract]   [Full Text] [Related]  

  • 39. [Partial rebreathing method (author's transl)].
    Nishida O
    Kokyu To Junkan; 1974 Feb; 22(2):117-26. PubMed ID: 4857438
    [No Abstract]   [Full Text] [Related]  

  • 40. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis.
    Sharma OP; Johnson R
    Chest; 1988 Aug; 94(2):343-6. PubMed ID: 3135156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.